PortfoliosLab logoPortfoliosLab logo
ANIP vs. VZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ANIP vs. VZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ANI Pharmaceuticals, Inc. (ANIP) and Verizon Communications Inc. (VZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ANIP achieves a 3.47% return, which is significantly lower than VZ's 21.97% return. Over the past 10 years, ANIP has underperformed VZ with an annualized return of 4.07%, while VZ has yielded a comparatively higher 4.44% annualized return.


ANIP

1D
0.04%
1M
0.99%
YTD
3.47%
6M
1.60%
1Y
31.49%
3Y*
18.03%
5Y*
18.57%
10Y*
4.07%

VZ

1D
2.49%
1M
1.91%
YTD
21.97%
6M
21.50%
1Y
18.98%
3Y*
18.39%
5Y*
2.74%
10Y*
4.44%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ANIP vs. VZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ANIP
ANI Pharmaceuticals, Inc.
3.47%42.80%0.25%37.06%-12.70%58.68%-52.91%36.98%-30.15%6.32%
VZ
Verizon Communications Inc.
21.97%8.86%13.14%2.71%-20.02%-7.55%-0.13%13.83%11.26%3.97%

Correlation

The correlation between ANIP and VZ is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jul 3, 2000

0.11

The correlation between ANIP and VZ shifts across timeframes, from -0.03 (1 year) to 0.12 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ANIP:

$1.76B

VZ:

$202.54B

EPS

ANIP:

$4.26

VZ:

$4.10

PE Ratio

ANIP:

19.17

VZ:

11.72

PS Ratio

ANIP:

1.86

VZ:

1.46

PB Ratio

ANIP:

3.13

VZ:

1.96

Total Revenue (TTM)

ANIP:

$923.71M

VZ:

$139.15B

Gross Profit (TTM)

ANIP:

$486.11M

VZ:

$81.89B

EBITDA (TTM)

ANIP:

$234.71M

VZ:

$48.65B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ANIP vs. VZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANIP
ANIP Risk / Return Rank: 6767
Overall Rank
ANIP Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ANIP Sortino Ratio Rank: 7171
Sortino Ratio Rank
ANIP Omega Ratio Rank: 6767
Omega Ratio Rank
ANIP Calmar Ratio Rank: 6666
Calmar Ratio Rank
ANIP Martin Ratio Rank: 6262
Martin Ratio Rank

VZ
VZ Risk / Return Rank: 6868
Overall Rank
VZ Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
VZ Sortino Ratio Rank: 6868
Sortino Ratio Rank
VZ Omega Ratio Rank: 6666
Omega Ratio Rank
VZ Calmar Ratio Rank: 7070
Calmar Ratio Rank
VZ Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANIP vs. VZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and Verizon Communications Inc. (VZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ANIPVZDifference
Sharpe ratioReturn per unit of total volatility

+0.05

Sortino ratioReturn per unit of downside risk

+0.19

Omega ratioGain probability vs. loss probability

1.19

1.18

+0.01

Calmar ratioReturn relative to maximum drawdown

1.10

1.43

-0.33

Martin ratioReturn relative to average drawdown

2.06

3.06

-1.00

ANIP vs. VZ - Sharpe Ratio Comparison

The current ANIP Sharpe Ratio is 0.89, which is comparable to the VZ Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of ANIP and VZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ANIP vs. VZ - Drawdown Comparison

The maximum ANIP drawdown since its inception was -98.81%, which is greater than VZ's maximum drawdown of -50.66%. Use the drawdown chart below to compare losses from any high point for ANIP and VZ.


Loading charts...

Drawdown Indicators


ANIPVZDifference

Max Drawdown

Largest peak-to-trough decline

-98.81%

-50.66%

-48.15%

Max Drawdown (1Y)

Largest decline over 1 year

-28.66%

-13.32%

-15.34%

Max Drawdown (3Y)

Largest decline over 3 years

-28.66%

-14.93%

-13.73%

Max Drawdown (5Y)

Largest decline over 5 years

-59.38%

-38.38%

-21.00%

Max Drawdown (10Y)

Largest decline over 10 years

-72.96%

-41.21%

-31.75%

Current Drawdown

Current decline from peak

-81.85%

-4.96%

-76.89%

Average Drawdown

Average peak-to-trough decline

-79.39%

-14.82%

-64.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.33%

6.23%

+9.10%

Volatility

ANIP vs. VZ - Volatility Comparison

ANI Pharmaceuticals, Inc. (ANIP) has a higher volatility of 9.14% compared to Verizon Communications Inc. (VZ) at 6.87%. This indicates that ANIP's price experiences larger fluctuations and is considered to be riskier than VZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ANIPVZDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.14%

6.87%

+2.27%

Volatility (6M)

Calculated over the trailing 6-month period

24.38%

17.91%

+6.47%

Volatility (1Y)

Calculated over the trailing 1-year period

35.56%

22.78%

+12.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.29%

21.66%

+24.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.26%

20.36%

+27.90%

Dividends

ANIP vs. VZ - Dividend Comparison

ANIP has not paid dividends to shareholders, while VZ's dividend yield for the trailing twelve months is around 5.75%.


PositionTTM20252024202320222021202020192018201720162015
ANIP
ANI Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VZ
Verizon Communications Inc.
5.75%6.68%6.68%6.96%6.53%4.85%4.21%3.95%4.22%4.39%4.26%4.79%

Financials

ANIP vs. VZ - Financials Comparison

This section allows you to compare key financial metrics between ANI Pharmaceuticals, Inc. and Verizon Communications Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B20222023202420252026
237.46M
34.44B
(ANIP) Total Revenue
(VZ) Total Revenue
Values in USD except per share items

ANIP vs. VZ - Profitability Comparison

The chart below illustrates the profitability comparison between ANI Pharmaceuticals, Inc. and Verizon Communications Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
60.3%
Portfolio components
ANIP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 237.46M. Therefore, the gross margin over that period was 0.0%.

VZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verizon Communications Inc. reported a gross profit of 20.77B and revenue of 34.44B. Therefore, the gross margin over that period was 60.3%.

ANIP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported an operating income of 38.89M and revenue of 237.46M, resulting in an operating margin of 16.4%.

VZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verizon Communications Inc. reported an operating income of 8.24B and revenue of 34.44B, resulting in an operating margin of 23.9%.

ANIP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.49M and revenue of 237.46M, resulting in a net margin of 12.4%.

VZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verizon Communications Inc. reported a net income of 5.05B and revenue of 34.44B, resulting in a net margin of 14.7%.


Frequently Asked Questions


ANIP and VZ have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANIP has higher volatility (9.14%) compared to VZ (6.87%). In terms of maximum drawdown, ANIP dropped -98.81% vs VZ's -50.66%.

ANIP currently has the higher Sharpe Ratio (0.89 vs 0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ANIP and VZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer